Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. May 14, 2014; 20(18): 5353-5362
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5353
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5353
Pros and cons of liver transplantation in human immunodeficiency virus infected recipients
Umberto Baccarani, Gian Luigi Adani, Dario Lorenzin, Andrea Risaliti, Liver Transplant Unit, Department of Medical and Biological Sciences, University Hospital of Udine, 33100 Udine, Italy
Elda Righi, Matteo Bassetti, Division of Infectious Disease, University Hospital of Udine, 33100 Udine, Italy
Alberto Pasqualucci, Department of Anaesthesiology, University of Perugia, 33100 Udine, Italy
Author contributions: Baccarani U and Righi E equally contributed to conception and design, acquisition of data, or analysis and interpretation of data, drafted and revised the article critically for important intellectual content; Adani GL and Lorenzin D made substantial contributions to acquisition of data or analysis and interpretation; Pasqualucci A, Bassetti M and Risaliti A made final approval of the version to be published.
Correspondence to: Umberto Baccarani, MD, PhD, FEBS, Liver Transplant Unit, Department of Medical and Biological Sciences, University Hospital of Udine, P.le S.M. della Misericordia 15, Pad. Petracco, 33100 Udine, Italy. umberto.baccarani@uniud.it
Telephone: +39-432-559902 Fax: +39-432-559552
Received: October 21, 2013
Revised: December 5, 2013
Accepted: January 19, 2014
Published online: May 14, 2014
Processing time: 204 Days and 17.6 Hours
Revised: December 5, 2013
Accepted: January 19, 2014
Published online: May 14, 2014
Processing time: 204 Days and 17.6 Hours
Core Tip
Core tip: This article reviews the most recent literature in the field of liver transplantation in human immunodeficiency virus (HIV) positive recipients with special focus on hepatitis C virus/HIV coinfection and hepatocellular carcinoma in HIV recipients. This field of research is one of the most intriguing up to now since end-stage liver disease has become the first cause of death in HIV patients and the request for liver transplantation in this subgroup of HIV positive patients is going to increase over time.